A Two-part Study of the Effects of MK-1029 in Allergen-Challenged Asthmatics (MK-1029-003)
Clinical trial NCT01343407 · COMPLETED
Trial details
- NCT number
- NCT01343407
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-19
- Primary completion
- 2012-01-09
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.